0001354457-18-000479.txt : 20181115
0001354457-18-000479.hdr.sgml : 20181115
20181115093226
ACCESSION NUMBER: 0001354457-18-000479
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20181115
DATE AS OF CHANGE: 20181115
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Origo Acquisition Corp
CENTRAL INDEX KEY: 0001619551
STANDARD INDUSTRIAL CLASSIFICATION: PERIODICALS: PUBLISHING OR PUBLISHING AND PRINTING [2721]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1130
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36757
BUSINESS ADDRESS:
STREET 1: 24 NEW ENGLAND EXECUTIVE PARK
STREET 2: SUITE 105
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 24 NEW ENGLAND EXECUTIVE PARK
STREET 2: SUITE 105
CITY: BURLINGTON
STATE: MA
ZIP: 01803
FORMER COMPANY:
FORMER CONFORMED NAME: CB Pharma Acquisition Corp.
DATE OF NAME CHANGE: 20140915
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: The Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
The Nasdaq Stock Market LLC
0001619551
Origo Acquisition Corp
001-36757
10990 Wilshire Blvd, Penthouse
Los Angeles
CA
CALIFORNIA
90024
212-554-4366
Ordinary Shares
17 CFR 240.12d2-2(b)
Amy Horton
Hearings Advisor
2018-11-15
EX-99.25
2
oacqdelistreason.txt
On August 23, 2017, Nasdaq Listing Qualifications staff (Staff) notified
Origo Acquisition Corporation (Company) that it determined to delist the
Company based on Rule 5505(a)(3). On August 30, 2017, the Company
exercised its right to appeal the Staff's determination to the Listing
Qualifications Hearings Panel (Panel) pursuant to Rule 5815. A Panel
hearing was held on October 12, 2017. On October 23, 2017, the Panel
issued a decision that granted the Company through February 19, 2018
to consummate a transaction that would cause it to regain compliance.
However, after the Company informed the Panel that it would not meet
this new deadline, the Panel issued a delisting decision on
February 20, 2018. On March 7, 2018, the Company exercised its right
to appeal the Panel decision to the Nasdaq Listing and Hearing Review
Council (Council) pursuant to Rule 5820(a). On May 17, 2018, the Council
issued a decision that affirmed the Panel decision to delist the
Companys securities. On September 26, 2018, the Company was provided
notice that the Nasdaq Board of Directors declined to call the Council
decision for review pursuant to Rule 5825(a).